Physician profile
Paul L Odonnell
NPI 1407825433
$3,487.47
in general payments reported to CMS, 2019-2025
16 companies · $725 in 2025
The $725 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,037 · 2020: $15.08 · 2021: $15.50 · 2022: $39.20 · 2023: $343 · 2024: $313 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036 · Travel and Lodging: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.17 |
| Travel and Lodging | $344.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,506.68 | 2019-2025 | Ranger, Eluvia |
| W. L. Gore & Associates, INC. | $616.35 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Endoprosthesis |
| Medtronic Vascular, INC. | $241.62 | 2019 | |
| Cook Medical LLC | $236.73 | 2025 | Zenith Alpha |
| Medtronic, INC. | $146.62 | 2023-2025 | Abre, Absorbatack, In.Pact Av |
| Cardinal Health 200 LLC | $146.33 | 2019-2020 | |
| Penumbra, INC. | $128.47 | 2019 | |
| Cook Incorporated | $108.07 | 2025 | Zenith |
| Philips North America LLC | $103.88 | 2019 | |
| Stryker Corporation | $54.97 | 2025 | Artix Mt |
| Surmodics, INC. | $44.10 | 2023 | Pounce Thrombectomy System, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Venclose INC. | $43.69 | 2019 | |
| Lemaitre Vascular, INC. | $38.29 | 2024 | Artegraft Vascular Graft |
| Angiodynamics, INC. | $29.17 | 2019-2021 | |
| Covidien LP | $23.74 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $18.76 | 2024 | Venovo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Odonnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.